Publications

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

 5
Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

Tags:

Previous Article

How muscle cells grow and stay healthy

Next Article

MicroRNA-based gene therapy to treat ALS 

Related Posts

PDIA3 defines a novel subset of adipose macrophages to exacerbate the development of obesity and metabolic disorders

PDIA3 defines a novel subset of adipose macrophages to ...

 89

What Is Chronic Migraine?

What Is Chronic Migraine?

 109

Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments

Ulcerative colitis: clinical biomarkers, therapeutic ta...

 145